$AMPE Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
on September 21, 2021
News
and Tags: AMPE, AMPE News, Ampio Pharmaceuticals Inc., Ampio Pharmaceuticals Inc. News
with 0 comments
Time:
9:15 AM
Symbol:
AMPE
Source:
PR Newswire
$AMPE Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)
on September 15, 2021
News
and Tags: AMPE, AMPE News, Ampio Pharmaceuticals Inc., Ampio Pharmaceuticals Inc. News
with 0 comments
Time:
9:15 AM
Symbol:
AMPE
Source:
PR Newswire
$AMPE Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
on August 11, 2021
News
and Tags: AMPE, AMPE News, Ampio Pharmaceuticals Inc., Ampio Pharmaceuticals Inc. News
with 0 comments
Time:
9:15 AM
Symbol:
AMPE
Source:
PR Newswire
$AMPE Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
on May 21, 2021
News
and Tags: AMPE, AMPE News, Ampio Pharmaceuticals Inc., Ampio Pharmaceuticals Inc. News
with 0 comments
Time:
9:15 AM
Symbol:
AMPE
Source:
PR Newswire